nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS1—ulcerative colitis	0.259	0.636	CbGaD
Phenylbutazone—PTGS2—ulcerative colitis	0.148	0.364	CbGaD
Phenylbutazone—PTGS2—Olsalazine—ulcerative colitis	0.0642	0.121	CbGbCtD
Phenylbutazone—PTGS2—Balsalazide—ulcerative colitis	0.0572	0.107	CbGbCtD
Phenylbutazone—PTGS1—Olsalazine—ulcerative colitis	0.0542	0.102	CbGbCtD
Phenylbutazone—PTGS1—Balsalazide—ulcerative colitis	0.0483	0.0907	CbGbCtD
Phenylbutazone—PTGS2—Mesalazine—ulcerative colitis	0.0457	0.0859	CbGbCtD
Phenylbutazone—PTGS1—Mesalazine—ulcerative colitis	0.0386	0.0725	CbGbCtD
Phenylbutazone—SLC22A8—Mercaptopurine—ulcerative colitis	0.0333	0.0626	CbGbCtD
Phenylbutazone—PTGS2—Sulfasalazine—ulcerative colitis	0.0256	0.048	CbGbCtD
Phenylbutazone—PTGS2—Triamcinolone—ulcerative colitis	0.0256	0.048	CbGbCtD
Phenylbutazone—PTGS2—Betamethasone—ulcerative colitis	0.0219	0.0412	CbGbCtD
Phenylbutazone—PTGS1—Sulfasalazine—ulcerative colitis	0.0216	0.0405	CbGbCtD
Phenylbutazone—CYP3A4—Budesonide—ulcerative colitis	0.0149	0.028	CbGbCtD
Phenylbutazone—PTGS2—Dexamethasone—ulcerative colitis	0.0128	0.0239	CbGbCtD
Phenylbutazone—CYP2C9—Nicotine—ulcerative colitis	0.0112	0.021	CbGbCtD
Phenylbutazone—CYP2C9—Cholecalciferol—ulcerative colitis	0.01	0.0188	CbGbCtD
Phenylbutazone—CYP3A4—Methylprednisolone—ulcerative colitis	0.00666	0.0125	CbGbCtD
Phenylbutazone—CYP3A4—Nicotine—ulcerative colitis	0.00649	0.0122	CbGbCtD
Phenylbutazone—CYP3A4—Cholecalciferol—ulcerative colitis	0.00582	0.0109	CbGbCtD
Phenylbutazone—CYP3A4—Triamcinolone—ulcerative colitis	0.00505	0.00948	CbGbCtD
Phenylbutazone—CYP2C9—Dexamethasone—ulcerative colitis	0.00433	0.00814	CbGbCtD
Phenylbutazone—CYP3A4—Betamethasone—ulcerative colitis	0.00433	0.00813	CbGbCtD
Phenylbutazone—CYP3A4—Prednisolone—ulcerative colitis	0.00428	0.00803	CbGbCtD
Phenylbutazone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00405	0.00761	CbGbCtD
Phenylbutazone—CYP3A4—Prednisone—ulcerative colitis	0.00404	0.00758	CbGbCtD
Phenylbutazone—CYP3A4—Dexamethasone—ulcerative colitis	0.00252	0.00473	CbGbCtD
Phenylbutazone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.00179	0.0329	CbGpPWpGaD
Phenylbutazone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00179	0.0329	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00154	0.0283	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.00148	0.0271	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.00126	0.023	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.00124	0.0227	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00123	0.0225	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—ulcerative colitis	0.00106	0.0194	CbGpPWpGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000872	0.016	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000822	0.0151	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000743	0.0136	CbGpPWpGaD
Phenylbutazone—Phenoxybenzamine—CALM3—ulcerative colitis	0.000688	0.237	CrCbGaD
Phenylbutazone—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000662	0.247	CbGdCrCtD
Phenylbutazone—PTGIS—Adipogenesis—MIF—ulcerative colitis	0.000641	0.0118	CbGpPWpGaD
Phenylbutazone—PTGIS—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000576	0.0106	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000567	0.0104	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000564	0.0103	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000564	0.0103	CbGpPWpGaD
Phenylbutazone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000555	0.0102	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000504	0.00924	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000474	0.0087	CbGpPWpGaD
Phenylbutazone—PTGIS—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000468	0.00859	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000439	0.00805	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000435	0.00798	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000435	0.00797	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.00043	0.00789	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.00043	0.00789	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000386	0.00708	CbGpPWpGaD
Phenylbutazone—Oxaprozin—PTGS1—ulcerative colitis	0.000368	0.127	CrCbGaD
Phenylbutazone—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000361	0.00662	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000359	0.00658	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000359	0.00658	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000351	0.00644	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000332	0.00608	CbGpPWpGaD
Phenylbutazone—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.00032	0.119	CbGdCrCtD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000315	0.00578	CbGpPWpGaD
Phenylbutazone—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000315	0.118	CbGdCrCtD
Phenylbutazone—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000315	0.118	CbGdCrCtD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000313	0.00574	CbGpPWpGaD
Phenylbutazone—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000308	0.115	CbGdCrCtD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000307	0.00562	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—PTGS1—ulcerative colitis	0.000306	0.00561	CbGpPWpGaD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000302	0.00554	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000288	0.00529	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000279	0.00512	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000277	0.00508	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000268	0.00492	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000268	0.00491	CbGpPWpGaD
Phenylbutazone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000266	0.00487	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000256	0.0047	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000256	0.0047	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000249	0.00456	CbGpPWpGaD
Phenylbutazone—Diphenhydramine—SLC22A5—ulcerative colitis	0.000243	0.0839	CrCbGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000224	0.0041	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000221	0.00405	CbGpPWpGaD
Phenylbutazone—Oxaprozin—PTGS2—ulcerative colitis	0.000211	0.0726	CrCbGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.00021	0.00385	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000204	0.00374	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—ulcerative colitis	0.000202	0.00371	CbGpPWpGaD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000201	0.00368	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000195	0.00358	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000195	0.00358	CbGpPWpGaD
Phenylbutazone—Fosphenytoin—ALB—ulcerative colitis	0.000195	0.0673	CrCbGaD
Phenylbutazone—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000193	0.0721	CbGdCrCtD
Phenylbutazone—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.00019	0.071	CbGdCrCtD
Phenylbutazone—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.00019	0.071	CbGdCrCtD
Phenylbutazone—PTGIS—Adipogenesis—PPARG—ulcerative colitis	0.000186	0.00342	CbGpPWpGaD
Phenylbutazone—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000186	0.0693	CbGdCrCtD
Phenylbutazone—Protriptyline—ABCB1—ulcerative colitis	0.000182	0.0627	CrCbGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000181	0.00331	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000175	0.00322	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000175	0.0032	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000174	0.0032	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000169	0.0031	CbGpPWpGaD
Phenylbutazone—Phenoxybenzamine—ADRB2—ulcerative colitis	0.000169	0.0581	CrCbGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000168	0.00309	CbGpPWpGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—ulcerative colitis	0.000166	0.0573	CrCbGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000166	0.00304	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000163	0.00299	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000163	0.00299	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000162	0.00297	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.00016	0.00293	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CHP1—ulcerative colitis	0.00015	0.00275	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000147	0.00269	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000146	0.00267	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000145	0.00267	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000145	0.00266	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000144	0.00264	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000142	0.0026	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000141	0.00258	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000139	0.00254	CbGpPWpGaD
Phenylbutazone—Phenprocoumon—ALB—ulcerative colitis	0.000134	0.0461	CrCbGaD
Phenylbutazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000133	0.00244	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000133	0.00244	CbGpPWpGaD
Phenylbutazone—Diphenhydramine—PTGS1—ulcerative colitis	0.000133	0.0457	CrCbGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00013	0.00239	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00013	0.00239	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000128	0.00234	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000127	0.00232	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000126	0.00232	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CHP1—ulcerative colitis	0.000125	0.0023	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000124	0.00227	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000122	0.00223	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SEL1L—ulcerative colitis	0.000119	0.00218	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000117	0.00216	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—STAT3—ulcerative colitis	0.000114	0.0021	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	0.000114	0.0021	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000113	0.00206	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.000111	0.00204	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.00011	0.00202	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—DLD—ulcerative colitis	0.000108	0.00199	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LTF—ulcerative colitis	0.000107	0.00196	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TGFB1—ulcerative colitis	0.000106	0.00195	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000102	0.00186	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	9.93e-05	0.00182	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	9.93e-05	0.00182	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—ulcerative colitis	9.9e-05	0.00182	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	9.77e-05	0.00179	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	9.68e-05	0.00178	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	9.31e-05	0.00171	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	9.19e-05	0.00169	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	9.08e-05	0.00167	CbGpPWpGaD
Phenylbutazone—Fentanyl—ABCB1—ulcerative colitis	9.07e-05	0.0313	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—ulcerative colitis	9.02e-05	0.0311	CrCbGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	8.81e-05	0.00162	CbGpPWpGaD
Phenylbutazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	8.77e-05	0.00161	CbGpPWpGaD
Phenylbutazone—Phenytoin—ALB—ulcerative colitis	8.62e-05	0.0297	CrCbGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	8.46e-05	0.00155	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	8.44e-05	0.00155	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.35e-05	0.00153	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.33e-05	0.00153	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.29e-05	0.00152	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.29e-05	0.00152	CbGpPWpGaD
Phenylbutazone—Phenytoin—ABCB1—ulcerative colitis	8.22e-05	0.0284	CrCbGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	8.11e-05	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	8.02e-05	0.00147	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—ulcerative colitis	7.99e-05	0.00147	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	7.7e-05	0.00141	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC11A1—ulcerative colitis	7.6e-05	0.00139	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	7.46e-05	0.00137	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	7.29e-05	0.00134	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	7.13e-05	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	7.12e-05	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	7.04e-05	0.00129	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAML2—ulcerative colitis	6.83e-05	0.00125	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.7e-05	0.00123	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	6.43e-05	0.00118	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	6.34e-05	0.00116	CbGpPWpGaD
Phenylbutazone—Methadone—ABCB1—ulcerative colitis	6.22e-05	0.0214	CrCbGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.18e-05	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	6.16e-05	0.00113	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.14e-05	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	6.09e-05	0.00112	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.81e-05	0.00107	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—ALB—ulcerative colitis	5.75e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	5.73e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.72e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CALM3—ulcerative colitis	5.63e-05	0.00103	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	5.59e-05	0.00103	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	5.55e-05	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	5.53e-05	0.00101	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	5.35e-05	0.000981	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	5.3e-05	0.000972	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS1—ulcerative colitis	5.23e-05	0.00096	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	5.19e-05	0.000952	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.16e-05	0.000947	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.15e-05	0.000944	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	5.11e-05	0.000938	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.1e-05	0.000936	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.09e-05	0.000934	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	5.03e-05	0.000923	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	4.94e-05	0.000907	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.81e-05	0.000882	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CALM3—ulcerative colitis	4.71e-05	0.000864	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.67e-05	0.000856	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.55e-05	0.000835	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.5e-05	0.000826	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—ALB—ulcerative colitis	4.38e-05	0.000804	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.35e-05	0.000799	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.24e-05	0.000779	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	4.16e-05	0.000763	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ADCY5—ulcerative colitis	4.08e-05	0.000749	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	4.03e-05	0.00074	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CHP1—ulcerative colitis	3.85e-05	0.000707	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	3.75e-05	0.000688	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCB1—ulcerative colitis	3.66e-05	0.000672	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.66e-05	0.000671	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CHP1—ulcerative colitis	3.65e-05	0.00067	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	3.6e-05	0.00066	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	3.58e-05	0.000658	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.56e-05	0.000653	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ADCY5—ulcerative colitis	3.42e-05	0.000627	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	3.39e-05	0.000622	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	3.36e-05	0.000616	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—DLD—ulcerative colitis	3.33e-05	0.00061	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.32e-05	0.000609	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	3.3e-05	0.000606	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	3.26e-05	0.000598	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CHP1—ulcerative colitis	3.06e-05	0.000561	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.97e-05	0.000545	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.92e-05	0.000536	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SEL1L—ulcerative colitis	2.9e-05	0.000532	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.87e-05	0.000526	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	2.8e-05	0.000513	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.77e-05	0.000508	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	2.66e-05	0.000489	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—DLD—ulcerative colitis	2.64e-05	0.000484	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	2.61e-05	0.000479	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LTF—ulcerative colitis	2.6e-05	0.000477	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPARG—ulcerative colitis	2.55e-05	0.000468	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—JAK2—ulcerative colitis	2.54e-05	0.000467	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—ulcerative colitis	2.41e-05	0.000442	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—ulcerative colitis	2.39e-05	0.000439	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	2.3e-05	0.000422	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ALB—ulcerative colitis	2.29e-05	0.00042	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.28e-05	0.000419	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.23e-05	0.000408	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	2.11e-05	0.000386	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CHP1—ulcerative colitis	2.03e-05	0.000372	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—ulcerative colitis	2.01e-05	0.000368	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.9e-05	0.000349	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.9e-05	0.000348	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—ulcerative colitis	1.87e-05	0.000343	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.86e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC11A1—ulcerative colitis	1.85e-05	0.00034	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.78e-05	0.000326	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.76e-05	0.000323	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DLD—ulcerative colitis	1.75e-05	0.000321	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—ulcerative colitis	1.73e-05	0.000318	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAML2—ulcerative colitis	1.67e-05	0.000306	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.58e-05	0.00029	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.57e-05	0.000287	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CALM3—ulcerative colitis	1.45e-05	0.000266	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.4e-05	0.000256	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.38e-05	0.000254	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CALM3—ulcerative colitis	1.37e-05	0.000252	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.34e-05	0.000245	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—ulcerative colitis	1.3e-05	0.000239	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.28e-05	0.000234	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.26e-05	0.00023	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DLD—ulcerative colitis	1.15e-05	0.000212	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CALM3—ulcerative colitis	1.15e-05	0.000211	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—ulcerative colitis	1.13e-05	0.000207	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ADCY5—ulcerative colitis	1.05e-05	0.000193	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ADCY5—ulcerative colitis	9.96e-06	0.000183	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.25e-06	0.00017	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—ulcerative colitis	8.94e-06	0.000164	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS1—ulcerative colitis	8.45e-06	0.000155	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADCY5—ulcerative colitis	8.34e-06	0.000153	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.32e-06	0.000153	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—ulcerative colitis	7.83e-06	0.000144	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CALM3—ulcerative colitis	7.61e-06	0.00014	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.28e-06	0.000133	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—ulcerative colitis	7.04e-06	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—ulcerative colitis	6.22e-06	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK2—ulcerative colitis	6.21e-06	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—ulcerative colitis	6.16e-06	0.000113	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—ulcerative colitis	5.92e-06	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—ulcerative colitis	5.89e-06	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—ulcerative colitis	5.59e-06	0.000103	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	5.58e-06	0.000102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADCY5—ulcerative colitis	5.52e-06	0.000101	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.02e-06	9.21e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—ulcerative colitis	4.56e-06	8.36e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—ulcerative colitis	4.22e-06	7.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—ulcerative colitis	4.12e-06	7.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.9e-06	7.16e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—ulcerative colitis	3.7e-06	6.79e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.64e-06	6.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—ulcerative colitis	3.24e-06	5.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—ulcerative colitis	3.18e-06	5.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.72e-06	4.98e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—ulcerative colitis	2.44e-06	4.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.14e-06	3.92e-05	CbGpPWpGaD
